Disparities in statin use following identification of coronary artery calcium

IF 4.3 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Charlotte C. Ellberg , Kavenpreet Bal , Edward Duran , Michael H. Criqui , Michael D. Shapiro , Harpreet S. Bhatia
{"title":"Disparities in statin use following identification of coronary artery calcium","authors":"Charlotte C. Ellberg ,&nbsp;Kavenpreet Bal ,&nbsp;Edward Duran ,&nbsp;Michael H. Criqui ,&nbsp;Michael D. Shapiro ,&nbsp;Harpreet S. Bhatia","doi":"10.1016/j.ajpc.2025.100990","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Coronary artery calcium (CAC) scoring is a useful tool for risk stratification in asymptomatic individuals, and current clinical practice is to utilize statins in individuals with CAC. A growing body of research has aimed to identify and mitigate health disparities and their relation to cardiovascular disease (CVD) risk. Likewise, studies have highlighted social determinants of health (SDOH) that contribute to health disparities in CVD.</div></div><div><h3>Objectives</h3><div>We aimed to evaluate whether disparities exist with regards to statin use after identification of CAC within the Multi-Ethnic Study of Atherosclerosis (MESA).</div></div><div><h3>Methods</h3><div>The associations between race/ethnicity, age, sex, primary language, and an aggregate SDOH score (calculated using previously defined methods) with statin use at short- and long-term follow-up were evaluated in logistic regression models with adjustment for traditional CVD risk factors in individuals with baseline CAC&gt;0 without baseline statin use.</div></div><div><h3>Results</h3><div>In the overall cohort, 3416 participants had CAC = 0, 1794 CAC 1–99, 757 CAC 100–300, and 847 CAC&gt;300 AU Mean age was 62 (10.2) years, 53 % (<em>n</em> = 3601) were women, 38.5 % (<em>n</em> = 2622) were non-Hispanic White, 27.8 % (<em>n</em> = 1892) were non-Hispanic Black, 22.0 % (<em>n</em> = 1892) were Hispanic and 11.8 % (<em>n</em> = 1892) were Chinese. At short-term follow up (median 1.6 years, <em>n</em> = 2665), those with a higher SDOH score (worse burden) (OR 0.39, 95 % CI 0.16–0.91), Hispanic (OR 0.59, 95 % CI 0.40–0.85) and Spanish speaking individuals (OR 0.51, 95 % CI 0.30–0.83) were less likely to report statin use following CAC identification. At long-term follow up (median 9.4 years, <em>n</em> = 2533), Black individuals (OR 0.71, 95 % CI 0.52–0.96), Chinese (OR 0.58, 95 % CI 0.39–0.86) and Chinese speaking individuals (OR 0.50, 95 % CI 0.33–0.76) were also less likely to report statin use following CAC identification, and a trend was noted for SDOH score (OR 0.53, 95 % CI 0.26–1.09).</div></div><div><h3>Conclusions</h3><div>This study identifies disparities in statin use by race/ethnicity, language, and social determinants of health after identification of CAC. While CAC is an effective tool for identifying atherosclerosis in asymptomatic individuals, more equitable use of subsequent therapy is needed.</div></div>","PeriodicalId":72173,"journal":{"name":"American journal of preventive cardiology","volume":"22 ","pages":"Article 100990"},"PeriodicalIF":4.3000,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of preventive cardiology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666667725000650","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Coronary artery calcium (CAC) scoring is a useful tool for risk stratification in asymptomatic individuals, and current clinical practice is to utilize statins in individuals with CAC. A growing body of research has aimed to identify and mitigate health disparities and their relation to cardiovascular disease (CVD) risk. Likewise, studies have highlighted social determinants of health (SDOH) that contribute to health disparities in CVD.

Objectives

We aimed to evaluate whether disparities exist with regards to statin use after identification of CAC within the Multi-Ethnic Study of Atherosclerosis (MESA).

Methods

The associations between race/ethnicity, age, sex, primary language, and an aggregate SDOH score (calculated using previously defined methods) with statin use at short- and long-term follow-up were evaluated in logistic regression models with adjustment for traditional CVD risk factors in individuals with baseline CAC>0 without baseline statin use.

Results

In the overall cohort, 3416 participants had CAC = 0, 1794 CAC 1–99, 757 CAC 100–300, and 847 CAC>300 AU Mean age was 62 (10.2) years, 53 % (n = 3601) were women, 38.5 % (n = 2622) were non-Hispanic White, 27.8 % (n = 1892) were non-Hispanic Black, 22.0 % (n = 1892) were Hispanic and 11.8 % (n = 1892) were Chinese. At short-term follow up (median 1.6 years, n = 2665), those with a higher SDOH score (worse burden) (OR 0.39, 95 % CI 0.16–0.91), Hispanic (OR 0.59, 95 % CI 0.40–0.85) and Spanish speaking individuals (OR 0.51, 95 % CI 0.30–0.83) were less likely to report statin use following CAC identification. At long-term follow up (median 9.4 years, n = 2533), Black individuals (OR 0.71, 95 % CI 0.52–0.96), Chinese (OR 0.58, 95 % CI 0.39–0.86) and Chinese speaking individuals (OR 0.50, 95 % CI 0.33–0.76) were also less likely to report statin use following CAC identification, and a trend was noted for SDOH score (OR 0.53, 95 % CI 0.26–1.09).

Conclusions

This study identifies disparities in statin use by race/ethnicity, language, and social determinants of health after identification of CAC. While CAC is an effective tool for identifying atherosclerosis in asymptomatic individuals, more equitable use of subsequent therapy is needed.
发现冠状动脉钙化后他汀类药物使用的差异
背景冠状动脉钙(CAC)评分是无症状个体风险分层的有用工具,目前的临床实践是在CAC患者中使用他汀类药物。越来越多的研究旨在确定和减轻健康差异及其与心血管疾病(CVD)风险的关系。同样,研究强调了导致心血管疾病健康差异的健康社会决定因素(SDOH)。目的:我们旨在评估在动脉粥样硬化多种族研究(MESA)中发现CAC后,他汀类药物的使用是否存在差异。方法:在短期和长期随访中,对基线CAC>;0且未基线使用他汀类药物的患者,采用逻辑回归模型,评估种族/民族、年龄、性别、主要语言和SDOH总评分(使用先前定义的方法计算)与他汀类药物使用之间的关系,并校正传统心血管疾病危险因素。结果在整个队列中,3416名参与者的CAC = 0, 1794名CAC 1-99, 757名CAC 100-300, 847名CAC>;300 AU,平均年龄62(10.2)岁,53% (n = 3601)为女性,38.5% (n = 2622)为非西班牙裔白人,27.8% (n = 1892)为非西班牙裔黑人,22.0% (n = 1892)为西班牙裔,11.8% (n = 1892)为中国人。在短期随访(中位1.6年,n = 2665)中,SDOH评分较高(负担较重)(OR 0.39, 95% CI 0.16-0.91)、西班牙裔(OR 0.59, 95% CI 0.40-0.85)和说西班牙语的个体(OR 0.51, 95% CI 0.30-0.83)在发现CAC后报告他汀类药物使用的可能性较小。在长期随访(中位9.4年,n = 2533)中,黑人(OR 0.71, 95% CI 0.52-0.96)、中国人(OR 0.58, 95% CI 0.39-0.86)和说中文的人(OR 0.50, 95% CI 0.33-0.76)在确诊CAC后报告他汀类药物使用的可能性也较低,SDOH评分也有趋势(OR 0.53, 95% CI 0.26-1.09)。结论:本研究确定了在确定CAC后,他汀类药物使用的种族/民族、语言和健康的社会决定因素的差异。虽然CAC是识别无症状个体动脉粥样硬化的有效工具,但需要更公平地使用后续治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American journal of preventive cardiology
American journal of preventive cardiology Cardiology and Cardiovascular Medicine
CiteScore
6.60
自引率
0.00%
发文量
0
审稿时长
76 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信